Cartesian Therapeutics, Inc. (RNAC) Market Cap

Cartesian Therapeutics, Inc. (RNAC) has a market capitalization of $197.6M, based on the latest available market data.

Financials updated after earnings reported 2025-09-30.

Sector: Healthcare
Industry: Biotechnology
Employees: 66
Exchange: NASDAQ Global Market
Headquarters: Watertown, MA, US
Website: https://selectabio.com

Loading company profile...

SEC Filings